|
Re: Merck's PIII Prostate trial, not the one with ZEN-3694, is halted for not showing improvement vs control
|
1
|
Zenith Epigenetics
|
Jan 27, 2023 10:49AM
|
|
Re: Merck's PIII Prostate trial, not the one with ZEN-3694, is halted for not showing improvement vs control
|
1
|
Zenith Epigenetics
|
Jan 27, 2023 09:55AM
|
|
Re: Merck's PIII Prostate trial, not the one with ZEN-3694, is halted for not showing improvement vs control
|
|
Zenith Epigenetics
|
Jan 27, 2023 06:59AM
|
|
Re: Merck's PIII Prostate trial, not the one with ZEN-3694, is halted for not showing improvement vs control
|
3
|
Zenith Epigenetics
|
Jan 26, 2023 02:04PM
|
|
Re: Some history
|
1
|
Resverlogix Corp.
|
Jan 26, 2023 08:56AM
|
|
Re: Merck's PIII Prostate trial, not the one with ZEN-3694, is halted for not showing improvement vs control
|
1
|
Zenith Epigenetics
|
Jan 26, 2023 06:12AM
|
|
Re: Some history
|
4
|
Resverlogix Corp.
|
Jan 25, 2023 08:49AM
|
|
Re: Epigenetics
|
1
|
Zenith Epigenetics
|
Jan 24, 2023 09:31AM
|
|
Re: Interesting read
|
|
Zenith Epigenetics
|
Jan 24, 2023 07:27AM
|
|
Exempt Distributions - Dec 9, 2022 & Jan 13, 2023
|
3
|
Zenith Epigenetics
|
Jan 18, 2023 04:54PM
|
|
Re: IR
|
2
|
Resverlogix Corp.
|
Jan 18, 2023 08:18AM
|
|
Re: IR
|
1
|
Resverlogix Corp.
|
Jan 18, 2023 06:16AM
|
|
Re: IR
|
3
|
Resverlogix Corp.
|
Jan 14, 2023 10:08AM
|
|
Re: Recent article; published in Clinical Epigenetics
|
2
|
Resverlogix Corp.
|
Jan 13, 2023 02:04PM
|
|
Re: IR
|
2
|
Resverlogix Corp.
|
Jan 10, 2023 09:13AM
|
|
Re: Another quarter and not a peep
|
1
|
Resverlogix Corp.
|
Jan 04, 2023 11:49AM
|
|
Re: Another quarter and not a peep
|
2
|
Resverlogix Corp.
|
Jan 04, 2023 09:43AM
|
|
Re: China- 1 Million daily COVID cases
|
6
|
Resverlogix Corp.
|
Dec 30, 2022 08:52AM
|
|
Re: China- 1 Million daily COVID cases
|
4
|
Resverlogix Corp.
|
Dec 29, 2022 10:42AM
|
|
China- 1 Million daily COVID cases
|
1
|
Resverlogix Corp.
|
Dec 27, 2022 06:49AM
|
